TY - JOUR
T1 - Comparative study on the carcinogenicity of N-nitrosodiethylamine, N-nitrosodhnethylamine, N-nitrosomorpholine, N-nitrosopyrrolidine and N-nitrosodi-N-propylamine to the lung of syrian golden hamsters following intermittent instillations to the trachea
AU - Ishinishi, Noburu
AU - Tanaka, Akiyo
AU - Hisanaga, Akira
AU - Inamasu, Takeo
AU - Hirata, Miyuki
N1 - Funding Information:
We are grateful to Professor M.Enjoji, Department of Pathology, Kyushu University, for direction and discussion, as well as to Miss K.Miller for editorial assistance. This study was supported by a Foundation from the Fukuoka Cancer Society.
PY - 1988/6
Y1 - 1988/6
N2 - N-Nitrosodiethylamine (NDEA), N-nitrosodimethylamine (NDMA), N-mtrosomorpholine (NMOR), N-nitrosopyrroli dine (NPYR) and N-nitrosodi-N-propylainine (NDPA) were instilled into the lungs of male Syrian golden hamsters by intratracheal instillatlons once a week for 15 weeks. The total doses given were 1.5 mg of each drug. As a control, hamsters were treated with the vehicle, phosphate buffer solution. During the total lifespan, tumor incidence rates in the respiratory organs were 100% in the NDEA group, 6% in the NDMA group, 43% in the NMOR group, 0% in the NPYR group, 72% in the NDPA group and 4% in the control group. The incidence rates in the liver were 19% in the NDMA group and 4% in the NPYR group. No liver tumors developed in the other groups. The carcinogenic potencies of these N-nitroso compounds to the respiratory organs was provisionally estimated to be in the following order: NDEA > NDPA> NMOR > NDMA ≒NPYR, at the 1.5 mg dosage level. However, the difference in the rates of tumor incidence between the NDMA or NPYR group and the control group was not significant.
AB - N-Nitrosodiethylamine (NDEA), N-nitrosodimethylamine (NDMA), N-mtrosomorpholine (NMOR), N-nitrosopyrroli dine (NPYR) and N-nitrosodi-N-propylainine (NDPA) were instilled into the lungs of male Syrian golden hamsters by intratracheal instillatlons once a week for 15 weeks. The total doses given were 1.5 mg of each drug. As a control, hamsters were treated with the vehicle, phosphate buffer solution. During the total lifespan, tumor incidence rates in the respiratory organs were 100% in the NDEA group, 6% in the NDMA group, 43% in the NMOR group, 0% in the NPYR group, 72% in the NDPA group and 4% in the control group. The incidence rates in the liver were 19% in the NDMA group and 4% in the NPYR group. No liver tumors developed in the other groups. The carcinogenic potencies of these N-nitroso compounds to the respiratory organs was provisionally estimated to be in the following order: NDEA > NDPA> NMOR > NDMA ≒NPYR, at the 1.5 mg dosage level. However, the difference in the rates of tumor incidence between the NDMA or NPYR group and the control group was not significant.
UR - http://www.scopus.com/inward/record.url?scp=0023928096&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023928096&partnerID=8YFLogxK
U2 - 10.1093/carcin/9.6.947
DO - 10.1093/carcin/9.6.947
M3 - Article
C2 - 3370758
AN - SCOPUS:0023928096
SN - 0143-3334
VL - 9
SP - 947
EP - 950
JO - Carcinogenesis
JF - Carcinogenesis
IS - 6
ER -